RxDoctor Payments Data

Athos Bousvaros

Pediatric Gastroenterology · Boston, MANPI 1528174885

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,800 of the $1,869 with a category attached, or 96.3%. Eli Lilly accounts for 96.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $1,800 and has fallen 96.5% since, to $63 in 2024.

$1,869in general payments, 2019–2025

Across 6 payments — averaging $311.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Bristol Myers Squibb$63
  • Travere Therapeutics, Inc.$6
$647,889in research payments, 2019–2025

Across 45 payments — averaging $14,398 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$388K
  • Bristol Myers Squibb$98K
  • AbbVie$78K
  • Pfizer$66K
  • Janssen Research & Development, LLC$18K

What the payments were for

  • Consulting fees$1,80096%
  • Food & beverage$633%
  • Education$60%

General payments by program year

19
20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,869 in reported general payments places this provider in the 70th percentile of 71 pediatric gastroenterology providers in Massachusetts.

See all pediatric gastroenterology providers in Massachusetts

Most prescribed under Part D

DrugClaimsCost to plans & patients
WaterWater For Irrigation,sterile11$678

Paid to pharmacies, not to this prescriber.

Other pediatric gastroenterology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →